• More COVID-19 Vaccines Are in the Pipeline as the U.S. Effort Ramps Up

    20 days ago - By Time

    A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak.
    Public health experts say more options in addition to the two vaccines now being dispensed - one made by Pfizer and its German partner BioNTech, the other by Moderna - are critical to amassing enough shots for the country and the world.
    The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the United States. Some 30,000 volunteers are needed to prove if...
    Read more ...